BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/27/2014 5:15:00 PM | Browse: 640 | Download: 652
Publication Name World Journal of Gastroenterology
Manuscript ID 6742
Country China
Received
2013-10-28 11:26
Peer-Review Started
2013-10-29 10:38
To Make the First Decision
2013-12-04 09:22
Return for Revision
2013-12-05 11:52
Revised
2013-12-17 14:19
Second Decision
2014-03-05 14:13
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-03-05 15:23
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-03-25 10:49
Typeset the Manuscript
2014-04-28 10:09
Publish the Manuscript Online
2014-05-18 12:31
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Infectious Diseases
Manuscript Type Topic Highlights
Article Title Optimization therapy for the treatment of chronic hepatitis B
Manuscript Source Invited Manuscript
All Author List En-Qiang Chen and Hong Tang
Funding Agency and Grant Number
Funding Agency Grant Number
National Twelve-Five Project of China 2012ZX10002007-001-003
National Twelve-Five Project of China 2013ZX10002001
Corresponding Author Hong Tang, Professor, Center of Infectious Diseases, West China Hospital of Sichuan University, No. 37 Guo Xue Xiang, Wuhou District, Chengdu 610041, Sichuan Province, China. htang6198@hotmail.com
Key Words Chronic hepatitis B; Nucleos(t)ide analog; Interferon; Suboptimal response; Optimization therapy
Core Tip Optimization therapy is a personalized strategy, and it aims to achieve profound and sustained inhibition of hepatitis B virus replication, and to reduce the likelihood of subsequent disease progression. The key points of optimization therapy are to initiate antiviral therapy with an appropriate agent at the correct time point based on baseline characteristics, and to timely adjust the treatment by dynamic monitoring of the on-treatment response. However, the current understanding of optimization therapy is still very limited, and many issues still need further research.
Publish Date 2014-05-18 12:31
Citation Chen EQ, Tang H. Optimization therapy for the treatment of chronic hepatitis B. World J Gastroenterol 2014; 20(19): 5730-5736
URL http://www.wjgnet.com/1007-9327/full/v20/i19/5730.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i19.5730
Full Article (PDF) WJG-20-5730.pdf
Full Article (Word) WJG-20-5730.doc
Manuscript File 6742-Review.doc
Answering Reviewers 6742-Answering reviewers.pdf
Copyright License Agreement 6742-Copyright assignment.pdf
Peer-review Report 6742-Peer review(s).pdf
Scientific Editor Work List 6742-Scientific editor work list.doc